Midwinter

Halo Dental Technologies to Showcase New Digital Dental Mirror at CDS Chicago Midwinter Meeting

Retrieved on: 
Wednesday, February 21, 2024
Midwinter, Dentist, Booth, Empowerment, Communication, Mouth, Dentistry, Comprehension, Health, CDA, Patient, Instrument, Convention, Wi-Fi, Halo, LED

MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Halo Dental Technologies, a pioneering developer of innovative dental technologies, is thrilled to announce its participation in the prestigious Chicago Dental Association's (CDA) Midwinter Meeting, taking place from February 22 to 24.

Key Points: 
  • MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Halo Dental Technologies, a pioneering developer of innovative dental technologies, is thrilled to announce its participation in the prestigious Chicago Dental Association's (CDA) Midwinter Meeting, taking place from February 22 to 24.
  • At Midwinter, one of dentistry’s most prestigious events, Halo Dental Technologies will unveil its revolutionary dental product innovation, the Halo Digital Mirror.
  • Halo Dental Technologies has reimagined this essential tool with its Halo Digital Mirror, offering a comprehensive technology solution designed to enhance communication and streamline the patient's oral health journey.
  • Spearheaded by Halo CEO Peter Khoury and backed by a deeply experienced board of dental practice professionals, Halo Dental Technologies introduces a new era of dental instruments with the release of its Halo Digital Mirror.

Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

Retrieved on: 
Tuesday, March 14, 2023
Research, Spanish Agency of Medicines and Medical Devices, Sale, Clinical trial, Genetic distance, Medication, Brain, AEMPS, Good laboratory practice, CTA, ARO, Cisplatin, State Administrative Expenses, AAV, Ear, Development, Administration, Medicines and Healthcare products Regulatory Agency, Patient, MHRA, Midwinter, FDA, GJB2, Regeneron Pharmaceuticals, Medical device, Health care, Hearing, Investigational New Drug, Therapy, IND, Congenital hearing loss, Pharmaceutical industry, Otorhinolaryngology, Decibel

BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update.

Key Points: 
  • BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financial results for the fourth quarter and full year ended December 31, 2022 and provided a corporate update.
  • Board of Directors Update: In October 2022, Decibel announced the appointment of Kevin F. McLaughlin to its Board of Directors.
  • Fourth Quarter and Full Year 2022 Financial Results:
    Cash Position: As of December 31, 2022, cash, cash equivalents and available-for-sale securities were $104.6 million, compared to $162.3 million as of December 31, 2021.
  • General and administrative expenses were $23.6 million for the full year 2022, compared to $20.4 million for the full year 2021.

TheraBreath™ Mouthrinse Team Introduces Dentists and Hygienists to ‘A Better Mouthrinse’ at the Chicago Dental Society Midwinter Meeting

Retrieved on: 
Tuesday, February 21, 2023
Other Consumer, Health, Discount, Variety, General Health, Men, Convenience Store, Retail, Family, Consumer, Dental, Parenting, Radioactive decay, Gingivitis, CPC, Midwinter, Plaque, McCormick Place, Patient, TheraBreath (brand), Dentistry, Enzyme, Remington (personal care brand), Arm, Sodium fluoride, Xerostomia, American Dental Society of Anesthesiology, Bad breath, Sulfate, Bacteria, Oxygen, Online shopping, Sulfur, Vaccine

Attendees can visit booth #2202 to learn why TheraBreath mouthrinses have over 90,000 five-star reviews online.

Key Points: 
  • Attendees can visit booth #2202 to learn why TheraBreath mouthrinses have over 90,000 five-star reviews online.
  • In addition to the adult rinses, TheraBreath™ products includes a lineup of dental hygiene products like mouthrinse for kids and TheraBreath™ Dry Mouth lozenges, all available to dental professionals.
  • TheraBreath will be featured at the Midwinter Meeting with a complete “Hygiene Squad” of Church and Dwight brands including: Waterpik®, Arm & Hammer™, and Spinbrush™.
  • For more information about TheraBreath products and how to order them for your dental office please visit www.therabreath.com/pro .

Hearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11-15

Retrieved on: 
Thursday, November 24, 2022
Cochlea, Translation, Hearing loss, ABR, Midwinter, Therapy, Ageing, Pharmacology, Cancer, Guinea, Apoptosis, Research, University, Gesellschaft mit beschränkter Haftung, Patient, Pharmaceutical industry, KCNQ4, Otorhinolaryngology

The ACOU085 presentation at the 2023 MidWinter Meeting will focus on preclinical pharmacology data from a guinea pig cisplatin-induced ototoxicity model, which supports the potential of ACOU085 treatment for preventing chemotherapy-induced hearing loss and outer hair cell apoptosis in cancer patients.

Key Points: 
  • The ACOU085 presentation at the 2023 MidWinter Meeting will focus on preclinical pharmacology data from a guinea pig cisplatin-induced ototoxicity model, which supports the potential of ACOU085 treatment for preventing chemotherapy-induced hearing loss and outer hair cell apoptosis in cancer patients.
  • ACOU082 is a proprietary small molecule Kv7.4 developed for oral administration with the potential to both acutely enhance natural hearing and preserve hearing capacity against e.g.
  • Furthermore, ACOU082 also significantly reduced the progression of age-related hearing loss as measured by ABR threshold shifts and compared to a placebo-treated, vehicle control group.
  • The company is dedicated to the identification and development of small molecules for effective prevention and treatment of different etiologies of hearing loss.

Hearing loss company Acousia Therapeutics to present data for lead candidates ACOU085 & ACOU082 at ARO 2023 MidWinter Meeting February 11-15

Retrieved on: 
Thursday, November 24, 2022
Cochlea, Translation, Hearing loss, ABR, Midwinter, Therapy, Ageing, Pharmacology, Cancer, Guinea, Apoptosis, Research, University, Gesellschaft mit beschränkter Haftung, Patient, Pharmaceutical industry, KCNQ4, Otorhinolaryngology

The ACOU085 presentation at the 2023 MidWinter Meeting will focus on preclinical pharmacology data from a guinea pig cisplatin-induced ototoxicity model, which supports the potential of ACOU085 treatment for preventing chemotherapy-induced hearing loss and outer hair cell apoptosis in cancer patients.

Key Points: 
  • The ACOU085 presentation at the 2023 MidWinter Meeting will focus on preclinical pharmacology data from a guinea pig cisplatin-induced ototoxicity model, which supports the potential of ACOU085 treatment for preventing chemotherapy-induced hearing loss and outer hair cell apoptosis in cancer patients.
  • ACOU082 is a proprietary small molecule Kv7.4 developed for oral administration with the potential to both acutely enhance natural hearing and preserve hearing capacity against e.g.
  • Furthermore, ACOU082 also significantly reduced the progression of age-related hearing loss as measured by ABR threshold shifts and compared to a placebo-treated, vehicle control group.
  • The company is dedicated to the identification and development of small molecules for effective prevention and treatment of different etiologies of hearing loss.

Civic Federal Credit Union Announces Firefighter, Foster Dad as Winner of Hybrid F-150 Truck

Retrieved on: 
Friday, January 28, 2022
LEED, Fire department, NCAFC, Partnership, F-150, National Fire Chiefs Council, Torque, Association, Midwinter, Family, Conference, Ford Motor Company, Civic

Michael Cary, a firefighter of eight years, is a newlywed and foster dad with a heart of service.

Key Points: 
  • Michael Cary, a firefighter of eight years, is a newlywed and foster dad with a heart of service.
  • Civic Federal Credit Union is dedicated to serving the needs of Fire Service and Rescue departments across North Carolina.
  • As North Carolina's first digital credit union, Civic is a member-led organization that serves local government employees, their families, and small businesses.
  • The credit union designs products and services which empower people to achieve financial goals, increase financial wellness and, in turn, create stronger communities.

Aptus Exchange to Exhibit at Chicago Dental Society's 155th Midwinter Meeting

Retrieved on: 
Wednesday, January 15, 2020
McCormick Place, Chicago, Midwinter, Geography of Illinois, Illinois, Cities in the United States

CHICAGO, Jan. 15, 2020 /PRNewswire/ --Aptus Exchange, a leading healthcare brokerage and advisory firm in Chicago, announced today that the company will be exhibiting at the Chicago Dental Society 2020 Midwinter Meeting, an annual event for the dental industry, at booth number 721.

Key Points: 
  • CHICAGO, Jan. 15, 2020 /PRNewswire/ --Aptus Exchange, a leading healthcare brokerage and advisory firm in Chicago, announced today that the company will be exhibiting at the Chicago Dental Society 2020 Midwinter Meeting, an annual event for the dental industry, at booth number 721.
  • AE provides integrated suite of service offerings, including comprehensive management consulting, marketing, strategic planning and transition services.
  • "The Midwinter Meeting is among the top three dental meetings in the United States," said AE CEO Michael Errin Rios.
  • The 2020 Midwinter Meeting will take place from Thursday, February 20 through Saturday, February 22 at McCormick Place, located at 2301 S. Indiana Ave., Chicago, IL 60616.